Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 100kWORD 16k
31 May 2016
Question for written answer E-004452-16
to the Commission
Rule 130
Momchil Nekov (S&D)

 Subject:  TTIP and the use of ractopamine, which is banned in the EU
 Answer in writing 

The EU is a world leader in terms of policies for animal health and high standards of food and food products for human consumption. Along with almost 160 third countries, the EU prohibits the use of the growth-promoting hormone ractopamine. In the USA, however, the substance is widely used: according to some estimates, in the rearing of 60-80% of all pigs produced in that country.

1. What is the Commission's position on the use of ractopamine as a growth promoter, both generally and in relation to the negotiations on the Transatlantic Trade and Investment Partnership (TTIP) agreement? 2. How will the Commission ensure that products produced in the USA from the meat of animals reared using this hormone are not allowed onto the EU market?

Original language of question: BG 
Legal notice